HOME > ARCHIVE

ARCHIVE

Healthcare Reform to Raise People's Burden by \1.5 Trillion: Korosho

July 15, 2002
Takeda, J&J to Promote Tylenol for Use on Empty Stomach

July 15, 2002
Outline for Intellectual Property Strategy Finalized

July 15, 2002
Asahi Beer Pham Merges Its Drug and Food Subsidiaries

July 15, 2002
REGULATORY NEWS IN BRIEF

July 15, 2002
OTC NEWS IN BRIEF

July 15, 2002
National Nagano Hospital to Encourage Use of Generics

July 15, 2002
RDKK Aims at Sales of \60 Bil., 15% Share in 2006

July 15, 2002
Monkasho Not Intending to Abolish Department of Pharmacy

July 15, 2002
Takara Bio Reshuffles Its Business Structure

July 15, 2002
GLs for Epidemiological Studies Enforced

July 15, 2002
Dainippon to Boost Overseas Sales to 7% in FY2006: President Miyatake

July 15, 2002
DIAGNOSTIC NEWS IN BRIEF

July 15, 2002
Takeda Expects SCOPE Results to Boost Sales of Candesartan

July 15, 2002
MEDICAL DEVICE NEWS IN BRIEF

July 15, 2002
1st-Class Products Invite 1st-Class People:Dr Aoki of Fujisawa

July 8, 2002
REGULATORY NEWS IN BRIEF

July 8, 2002
Korosho Compiles Report on Healthcare Devices

July 8, 2002
BULLETIN

July 8, 2002
MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF

July 8, 2002

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Beyond Elevidys: Next-Generation DMD Therapies Advance through Multiple Approaches

By Shinya Sato

The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…